- Home
- CORT vs RGEN Comparison
CORT vs RGEN Comparison
Compare CORT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- RGEN
- Stock Information
- Founded
- CORT 1998
- RGEN 1981
- Country
- CORT United States
- RGEN United States
- Employees
- CORT N/A
- RGEN N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- RGEN Medical/Dental Instruments
- Sector
- CORT Health Care
- RGEN Health Care
- Exchange
- CORT Nasdaq
- RGEN Nasdaq
- Market Cap
- CORT 7.1B
- RGEN 7.4B
- IPO Year
- CORT N/A
- RGEN N/A
- Fundamental
- Price
- CORT $70.23
- RGEN $123.24
- Analyst Decision
- CORT Strong Buy
- RGEN Buy
- Analyst Count
- CORT 4
- RGEN 12
- Target Price
- CORT $142.00
- RGEN $172.67
- AVG Volume (30 Days)
- CORT 1.4M
- RGEN 844.5K
- Earning Date
- CORT 05-05-2025
- RGEN 04-29-2025
- Dividend Yield
- CORT N/A
- RGEN N/A
- EPS Growth
- CORT 8.36
- RGEN N/A
- EPS
- CORT 1.14
- RGEN N/A
- Revenue
- CORT $685,446,000.00
- RGEN $650,429,000.00
- Revenue This Year
- CORT $36.81
- RGEN $12.61
- Revenue Next Year
- CORT $32.00
- RGEN $15.24
- P/E Ratio
- CORT $61.85
- RGEN N/A
- Revenue Growth
- CORT 30.93
- RGEN 4.88
- 52 Week Low
- CORT $25.35
- RGEN $102.97
- 52 Week High
- CORT $117.33
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- CORT 50.58
- RGEN 39.31
- Support Level
- CORT $68.92
- RGEN $125.31
- Resistance Level
- CORT $75.41
- RGEN $143.56
- Average True Range (ATR)
- CORT 3.76
- RGEN 6.86
- MACD
- CORT -0.19
- RGEN -1.22
- Stochastic Oscillator
- CORT 57.96
- RGEN 0.54
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.